JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 19 No. 1 31-35
© 1978 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klingensmith, W. C.
Right arrow Articles by Wagner, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klingensmith, W. C., III
Right arrow Articles by Wagner, H. N., Jr.

Lung Uptake of Tc-99m Sulfur Colloid in Liver and Spleen Imaging

William C. Klingensmith, III, Shirley L. Yang and Henry N. Wagner, Jr.

The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints contact: William C. Klingensmith III, Nuclear Medicine Service, VA Hospital, 1055 Clermont St., Denver, CO 80262.

ABSTRACT

Twenty-seven patients with increased lung uptake of technetium-99m sulfur colloid (TcSC) were studied as a group and after classification by the degree of lung uptake (15 patients mild, 6 moderate, and 6 marked) to determine survival rate and the incidence of associated abnormalities. Using life-table data based on all 27 patients, it is estimated that 74% would be alive at 6 mo; this is significantly higher (p < 0.02) than the 38% survival estimate at 6 mo for patients reported in the literature. Twenty-two of the 27 patients (81%) had increased splenic uptake of TcSC, 15 (56%) had splenomegaly, 17 (63%) had an abnormal liver image (enlargement or nonhomogeneity), and 9 (33%) had increased bone-marrow uptake. As the degree of lung uptake increased, there was a tendency for the survival rate to decrease and for the incidence of other abnormalities in the liver and spleen images to increase. This tendency was statistically significant (p < 0.05) for abnormal liver image, and also for increased bone-marrow uptake and splenomegaly when patients with moderate and marked lung uptake were combined and compared with patients with mild lung uptake. Increased lung uptake of TcSC is strongly associated with other abnormalities in the liver and spleen images, but is not necessarily associated with a poor prognosis, particularly when the degree of increased lung uptake is mild.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Singh, J. W. Pearce, L. N. Gamage, K. Janardhan, and S. Caldwell
Depletion of pulmonary intravascular macrophages inhibits acute lung inflammation
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L363 - L372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. D. Brain, R. M. Molina, M. M. DeCamp, and A. E. Warner
Effects of a perfluorochemical emulsion on the fate of circulating Pseudomonas aeruginosa
Am J Physiol Lung Cell Mol Physiol, June 1, 1999; 276(6): L1037 - L1045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1978 by the Society of Nuclear Medicine.